1/30
Innovation
Investing in Penn’s data science ecosystem
Through the Innovation in Data Engineering and Science Initiative, Penn aims to become a leader in data-driven approaches that can transform scientific discovery, engineering research, and technological innovation.
A record-breaking year for innovation
With its highest number of patents issued, commercial agreements, corporate-sponsored research funding, and licensing revenue receipts in a single period, the Penn Center for Innovation experienced a landmark fiscal year.
Penn launches $750M investment in science, engineering, and medicine
The investment will cover research in novel therapeutics and health-related initiatives, energy and sustainability, data engineering and science, and infrastructure to support physical science research over the next five years.
Celebrating five years of innovation, entrepreneurship, and creativity
Penn Today marks the anniversary of Pennovation Works, the University’s business incubator and laboratory space, with a look at the evolution of the site, its research and commercialization achievements, and a glimpse into the future.
Cancer care in Penn Medicine’s Pavilion: Reimagined, revitalized, and inclusive
The Pavilion is designed to bring research and clinical care together, while connecting patients and their families with their medical teams in innovative ways.
As The Power of Penn concludes, a look into its big impact
Penn Today chatted with Development and Alumni Relations’ John Zeller, who shared highlights of the University’s most recent fundraising campaign, and much more.
Drew Weissman and Katalin Karikó receive 2021 Lasker Award
Weissman and Karikó’s mRNA technology is recognized for enabling rapid development of highly effective COVID-19 vaccines
Penn establishes the Center for Precision Engineering for Health with $100 million commitment
The Center will conduct interdisciplinary, fundamental, and translational research in biomaterials that can create breakthroughs in improving health care and saving lives, including nanoparticle technologies to improve storage and distribution of COVID-19 mRNA vaccines.
Penn engineers will develop on-demand, on-site mRNA manufacturing
With an NSF grant, Penn Engineering researchers are developing a new manufacturing technique that would be able to produce mRNA sequences in a way that removes the need for cryogenic temperatures.
At-home COVID-19 results with the click of a smartphone
Penn researchers have developed a highly-sensitive rapid antigen test that can detect small loads of SARS-CoV-2.
In the News
Philly schools could be on the forefront of using AI. Here’s what that means
Penn has partnered with the Philadelphia School District to launch a pilot program to train teachers and administrators on how best to integrate artificial intelligence in city schools, featuring remarks from L. Michael Golden of the Graduate School of Education.
FULL STORY →
Bosses struggle to police workers’ use of AI
Ethan Mollick of the Wharton School says that workers who privately use generative AI to accelerate their work might not be willing to admit it.
FULL STORY →
Supreme Court will hear TikTok’s challenge to looming U.S. ban
Justin (Gus) Hurwitz of Penn Carey Law says that the heart of the TikTok ban case is balancing the First Amendment against both national security concerns and the court’s deference to Congress and the executive branch.
FULL STORY →
Family offices face hidden risks in making direct investments
According to a study by Raphael “Raffi” Amit of the Wharton School and colleagues, direct investments in private companies could mean taking on more risk than expected if family offices aren’t leveraging their resources.
FULL STORY →
When AI goes shopping: AI agents promise to lighten your purchasing load—if they can earn your trust
Ethan Mollick of the Wharton School says that the adoption of AI in everyday life will be gradual, as societal change typically lags behind technological advancement.
FULL STORY →
What a new innovation index tells us about Philadelphia
Penn is lauded for its research and development efforts, including the modified mRNA technique that was commercialized into a COVID vaccine and won its researchers a Nobel Prize last year.
FULL STORY →